Personalized shopping, stock trading, and online portals - all have become hallmarks to our new information driven culture that has become increasingly focused on the individual. Looking beyond these innovations, the focus on addressing the individual needs of patients, or more commonly known as personalized medicine, has become a focal point within the debates of healthcare reform. But is personalized medicine really something that we can enact within the confines of the current IT infrastructure and patient educational services?
Tags: Personalized Medicine, Product Strategy, Investor Strategy, Global Strategy, Patient Strategy
In a time when most conversations I have with clients revolve around how the global economical state of affairs is going to affect their marketing budgets for 2009, my response has been clear and unchanged - it's time to smarten up. Investors are more critical than ever on fiscal performance, managers have to keep close control of their spending and report on results, all of which is compounded by the FDA who is starting to crack down on claims made within DTC advertising. We have to stay focused, and more than ever, find ways to be efficient and strategic with our initiatives.
Tags: Online Marketing, Viral Marketing, DTC Advertising, Product Strategy, Global Strategy, Investor Strategy
Recently, I dove head first into the social media space. Sure, I develop social medial platforms for our clients, I’m on LinkedIn and occasionally, go onto Facebook to interact with friends and family, but I was always reluctant to take the full plunge. Part of my resistance was the fear of opening up a floodgate of communication that would be distracting and difficult to control. Instead the opposite has happened. I’ve found people I have not talked to in years, gotten involved in groups that have educated me on everything from design to politics, and generally have a new dynamic way of reaching out to my peer group.
Tags: Web 2.0, Social Media, Product Strategy, Patient Strategy, Global Strategy
This blog from Mark Senak at Eye on FDA is always worth reading and today addresses the digital literacy - or lack of it - within pharma companies. He makes some extremely pertinent comments on the use of digital media such as YouTube to address the lack of patient awareness of clinical trials and their value. I have posted an excerpt below.
I will be in San Diego Wednesday and Thursday and look forward to immersing myself in the BIO world for a couple of days. My main goal is to meet up with clients and industry friends and catch up on what they are doing. You can find out what panels I will be attending by following me on Twitter, or just send me a text message to 510-499-5859 and I will be happy to let you know what I am up to.